Back to Top

Current Opinion in Biotechnology (COB)

Publisher :

Elsevier

  • Biomedical Engineering
  • Molecular Biology
  • Chemical Engineering
  • +1

e-ISSN :

1879-0429

Issue Frequency :

Bi-Monthly

Impact Factor :

7.7

p-ISSN :

0958-1669

Est. Year :

1990

Mobile :

31204853767

Country :

United Kingdom

Language:

English

APC :

YES

Email :

nlinfo@sciencedirect.com

Journal Descriptions

Review articles in Current Opinion in Biotechnology are by invitation only. Current Opinion in Biotechnology (COBIOT) publishes authoritative, comprehensive, and systematic reviews. COBIOT helps specialists keep up to date with a clear and readable synthesis on current advances biotechnology. Expert authors annotate the most interesting papers from the expanding volume of information published today, saving valuable time and giving the reader insight on areas of importance. Current Opinion in Biotechnology is part of the Current Opinion and Research (CO+RE) suite of journals and is a companion to the new primary research, open access journal, Current Research in Biotechnology (CRBIOT). CO+RE journals leverage the Current Opinion legacy of editorial excellence, high-impact, and global reach to ensure they are a widely read resource that is integral to scientists workflow.


Current Opinion in Biotechnology (COB) is :

International, Peer-Reviewed, Open Access, Refereed, Biomedical Engineering, Molecular Biology, Chemical Engineering, Bioengineering , Online or Print, Bi-Monthly Journal

UGC Approved, ISSN Approved: P-ISSN - 0958-1669, E-ISSN - 1879-0429, Established in - 1990, Impact Factor - 7.7

Not Provide Crossref DOI

Indexed in Scopus, WoS

Not indexed in DOAJ, PubMed, UGC CARE

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile